Search

Your search keyword '"Winther, Jeanette F"' showing total 326 results
Start Over Author "Winther, Jeanette F"
326 results on '"Winther, Jeanette F"'

1. Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study

Author

Heymer, Emma J., Hawkins, Michael M., Winter, David L., Teepen, Jop C., Sunguc, Ceren, Ronckers, Cécile M., Allodji, Rodrigue S., Alessi, Daniela, Sugden, Elaine, Belle, Fabiën N., Bagnasco, Francesca, Byrne, Julianne, Bárdi, Edit, Garwicz, Stanislaw, Grabow, Desiree, Jankovic, Momcilo, Kaatsch, Peter, Kaiser, Melanie, Michel, Gisela, Schindera, Christina, Haddy, Nadia, Journy, Neige, Česen Mazić, Maja, Skinner, Roderick, Kok, Judith L., Gunnes, Maria W., Wiebe, Thomas, Sacerdote, Carlotta, Maule, Milena M., Terenziani, Monica, Jakab, Zsuzsanna, Winther, Jeanette F., Lähteenmäki, Päivi M., Zadravec Zaletel, Lorna, Haupt, Riccardo, Kuehni, Claudia E., Kremer, Leontien C., de Vathaire, Florent, Hjorth, Lars, and Reulen, Raoul C.

Published
2024
Full Text
View/download PDF

2. Risk of severe esophageal stricture among childhood cancer survivors – A population-based case-cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS)

Author

Hansen, Helena K., Asdahl, Peter H., Christensen, Jane, Pedersen, Camilla, Krøyer, Anja, Pontoppidan, Celina S., Holmqvist, Anna S., Hjorth, Lars, Wiebe, Thomas, Gudmundsdottir, Thorgerdur, de fine Licht, Sofie, Lassen-Ramshad, Yasmin, Seiersen, Klaus, Jørgensen, Morten, Laursen, Michael RT, Øfstaas, Hilde, Lähteenmäki, Päivi M., Smith, Susan A., Howell, Rebecca, Rechnitzer, Catherine, Hasle, Henrik, Winther, Jeanette F., and Kenborg, Line

Published
2024
Full Text
View/download PDF

4. Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study

Author

Sunguc, Ceren, Hawkins, Michael M., Winter, David L., Dudley, Isabelle M., Heymer, Emma J., Teepen, Jop C., Allodji, Rodrigue S., Belle, Fabiën N., Bagnasco, Francesca, Byrne, Julianne, Bárdi, Edit, Ronckers, Cécile M., Haddy, Nadia, Gudmundsdottir, Thorgerdur, Garwicz, Stanislaw, Jankovic, Momcilo, van der Pal, Helena J. H., Mazić, Maja Česen, Schindera, Christina, Grabow, Desiree, Maule, Milena M., Kaatsch, Peter, Kaiser, Melanie, Fresneau, Brice, Michel, Gisela, Skinner, Roderick, Wiebe, Thomas, Sacerdote, Carlotta, Jakab, Zsuzsanna, Gunnes, Maria Winther, Terenziani, Monica, Winther, Jeanette F., Lähteenmäki, Päivi M., Zaletel, Lorna Zadravec, Kuehni, Claudia E., Kremer, Leontien C., Haupt, Riccardo, de Vathaire, Florent, Hjorth, Lars, and Reulen, Raoul C.

Published
2023
Full Text
View/download PDF

6. Childhood cancer survivorship care during the COVID-19 pandemic: an international report of practice implications and provider concerns

Author

van den Oever, Selina R., Pluijm, Saskia M. F., Skinner, Rod, Glaser, Adam, Mulder, Renée L., Armenian, Saro, Bardi, Edit, Berger, Claire, Ehrhardt, Matthew J., Gilleland Marchak, Jordan, Haeusler, Gabrielle M., Hartogh, Jaap den, Hjorth, Lars, Kepak, Tomas, Kriviene, Izolda, Langer, Thorsten, Maeda, Miho, Márquez-Vega, Catalina, Michel, Gisela, Muraca, Monica, Najib, Mohamed, Nathan, Paul C., Panasiuk, Anna, Prasad, Maya, Roganovic, Jelena, Uyttebroeck, Anne, Winther, Jeanette F., Zadravec Zaletel, Lorna, van Dalen, Elvira C., van der Pal, Helena J. H., Hudson, Melissa M., and Kremer, Leontien C. M.

Published
2022
Full Text
View/download PDF

12. European PanCareFollowUp Recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer

Author

van Kalsbeek, Rebecca J., van der Pal, Helena J.H., Kremer, Leontien C.M., Bardi, Edit, Brown, Morven C., Effeney, Rachel, Winther, Jeanette F., Follin, Cecilia, den Hartogh, Jaap, Haupt, Riccardo, Hjorth, Lars, Kepak, Tomas, Kepakova, Katerina, Levitt, Gill, Loonen, Jacqueline J., Mangelschots, Marlies, Muraca, Monica, Renard, Marleen, Sabic, Harun, Schneider, Carina U., Uyttebroeck, Anne, Skinner, Roderick, and Mulder, Renée L.

Published
2021
Full Text
View/download PDF

13. The European multistakeholder PanCareFollowUp project: novel, person-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for cancer survivors and caregivers

Author

Kremer, Leontien C.M., Van der Pal, Helena J.H., Mulder, Renée L., Pluijm, Saskia M.F., van Kalsbeek, Rebecca J., Van den Oever, Selina R., Hjorth, Lars, Follin, Cecilia, Eriksson, Lill, Relander, Thomas, Engellau, Jacob, Fjordén, Karin, Bogefors, Karolina, Holmqvist, Anna Säll fors, Haupt, Riccardo, Muraca, Monica, Nicolas, Brigitte, Bagnasco, Francesca, Benvenuto, Marina, Aulicino, Anna, Laudisi, Luca, Araujo-Soares, Vera, Kepak, Tomas, Kepakova, Katerina, Hrstkova, Hana, Bajciova, Viera, Holikova, Marta, Strublova, Lucie, Uyttebroeck, Anne, Renard, Marleen, Jacobs, Sandra, Segers, Heidi, Van Helvoirt, Monique, Winther, Jeanette Falck, Mader, Luzius, Frederiksen, Line Elmerdahl, Andersen, Elisabeth Anne Wreford, Michel, Gisela, Boes, Stefan, Roser, Katharina, Loonen, Jacqueline, Hermens, Rosella, Göttgens, Irene, Bouwman, Eline, Stollman, Iridi, Penson, Adriaan, Skinner, Roderick, Brown, Morven C., Essiaf, Samira, Blondeel, Anne, Sciberras, William, Korevaar, Joke, Rijken, Mieke, Kienesberger, Anita, Den Hartogh, Jaap, Gsell, Hannah, Schneider, Carina, Hartogh, Jaap den, Bardi, Edit, Te Dorsthorst, Jeroen, van der Pal, Helena J.H., Winther, Jeanette F., O'Brien, Kylie, Frederiksen, Line E., Hermens, Rosella P.M.G., Korevaar, Joke C., Mangelschots, Marlies, van den Oever, Selina, Skinner, Rod, and Loonen, Jacqueline J.

Published
2021
Full Text
View/download PDF

14. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study

Author

Langer, Thorsten, Clemens, Eva, Broer, Linda, Maier, Lara, Uitterlinden, André G., de Vries, Andrica C.H., van Grotel, Martine, Pluijm, Saskia F.M., Binder, Harald, Mayer, Benjamin, von dem Knesebeck, Annika, Byrne, Julianne, van Dulmen-den Broeder, Eline, Crocco, Marco, Grabow, Desiree, Kaatsch, Peter, Kaiser, Melanie, Spix, Claudia, Kenborg, Line, Winther, Jeanette F., Rechnitzer, Catherine, Hasle, Henrik, Kepak, Tomas, van der Kooi, Anne-Lotte F., Kremer, Leontien C., Kruseova, Jarmila, Bielack, Stefan, Sorg, Benjamin, Hecker-Nolting, Stefanie, Kuehni, Claudia E., Ansari, Marc, Kompis, Martin, van der Pal, Heleen, Parfitt, Ross, Deuster, Dirk, Matulat, Peter, Tillmanns, Amelie, Tissing, Wim J.E., Beck, Jörn D., Elsner, Susanne, am Zehnhoff-Dinnesen, Antoinette, van den Heuvel-Eibrink, Marry M., and Zolk, Oliver

Published
2020
Full Text
View/download PDF

15. Multisystem burden of neurofibromatosis 1 in Denmark: registry- and population-based rates of hospitalizations over the life span

Author

Kenborg, Line, Duun-Henriksen, Anne Katrine, Dalton, Susanne O., Bidstrup, Pernille E., Doser, Karoline, Rugbjerg, Kathrine, Pedersen, Camilla, Krøyer, Anja, Johansen, Christoffer, Andersen, Klaus Kaae, Østergaard, John R., Hove, Hanne, Sørensen, Sven Asger, Riccardi, Vincent M., Mulvihill, John J., and Winther, Jeanette F.

Published
2020
Full Text
View/download PDF

17. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup

Author

Allodji, Rodrigue S., Hawkins, Mike M., Bright, Chloe J., Fidler-Benaoudia, Miranda M., Winter, David L., Alessi, Daniela, Fresneau, Brice, Journy, Neige, Morsellino, Vera, Bárdi, Edit, Bautz, Andrea, Byrne, Julianne, Feijen, Elizabeth (Lieke) AM., Teepen, Jop C., Vu-Bezin, Giao, Rubino, Carole, Garwicz, Stanislaw, Grabow, Desiree, Gudmundsdottir, Thorgerdur, Guha, Joyeeta, Hau, Eva-Maria, Jankovic, Momcilo, Kaatsch, Peter, Kaiser, Melanie, Linge, Helena, Muraca, Monica, Llanas, Damien, Veres, Cristina, Øfstaas, Hilde, Diallo, Ibrahima, Mansouri, Imene, Ronckers, Cecile M., Skinner, Roderick, Terenziani, Monica, Wesenberg, Finn, Wiebe, Thomas, Sacerdote, Carlotta, Jakab, Zsuzsanna, Haupt, Riccardo, Lähteenmäki, Päivi, Zaletel, Lorna Zadravec, Kuehni, Claudia E., Winther, Jeanette F., Michel, Gisela, Kremer, Leontien C.M., Hjorth, Lars, Haddy, Nadia, de Vathaire, Florent, and Reulen, Raoul C.

Published
2019
Full Text
View/download PDF

19. Pregnancy outcomes in female survivors of neuroblastoma: a short report from the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study

Author

Azizi, Arezo, primary, Norsker, Filippa N., additional, Kokla, Marietta, additional, Nielsen, Thomas T., additional, Holmqvist, Anna S., additional, Øra, Ingrid, additional, Vettenranta, Kim, additional, Øfstaas, Hilde, additional, Hasle, Henrik, additional, Rechnitzer, Catherine, additional, Winther, Jeanette F., additional, and Kenborg, Line, additional

Published
2023
Full Text
View/download PDF

23. Perceived barriers and facilitators to health behaviors in European childhood cancer survivors:A qualitative PanCareFollowUp study

Author

Bouwman, Eline, Pluijm, Saskia M.F., Stollman, Iridi, Araujo-Soares, Vera, Blijlevens, Nicole M.A., Follin, Cecilia, Winther, Jeanette F., Hjorth, Lars, Kepak, Tomas, Kepakova, Katerina, Kremer, Leontien C.M., Muraca, Monica, van der Pal, Helena J.H., Schneider, Carina, Uyttebroeck, Anne, Vercruysse, Gertrui, Skinner, Rod, Brown, Morven C., Hermens, Rosella P.M.G., and Loonen, Jacqueline J.

Subjects
cancer risk factors, cancer prevention, Cancer Survivors, Health Behavior, Humans, behavioral science, Focus Groups, Child, survival, Neoplasms/epidemiology, Qualitative Research, pediatric cancer
Abstract

Background: Healthy behaviors, that is, engaging in regular physical activities, maintaining a healthy diet, limiting alcohol consumption, and avoiding tobacco and drug use, decrease the risk of developing late adverse health conditions in childhood cancer survivors. However, childhood cancer survivors may experience barriers to adopting and maintaining healthy behaviors. This study aimed to assess these barriers and facilitators to health behavior adoption and maintenance in childhood cancer survivors. Methods: A focus group (n = 12) and semi-structured telephone interviews (n = 20) were conducted with a selected sample of European and Dutch childhood cancer survivors, respectively. The Theoretical Domains Framework (TDF) was used to inform the topic guide and analysis. Inductive thematic analysis was applied to identify categories relating to barriers and facilitators of health behavior adoption and maintenance, after which they were deductively mapped onto the TDF. Results: Ten TDF domains were identified in the data of which “Knowledge,” “Beliefs about consequences,” “Environmental context and resources,” and “Social influences” were most commonly reported. Childhood cancer survivors expressed a need for knowledge on the importance of healthy behaviors, possibly provided by healthcare professionals. They indicated physical and long-term benefits of healthy behaviors, available professional support, and a supporting and health-consciously minded work and social environment to be facilitators. Barriers were mostly related to a lack of available time and an unhealthy environment. Lastly, (social) media was perceived as both a barrier and a facilitator to healthy behaviors. Conclusion: This study has identified education and available professional support in health behaviors and the relevance of healthy behaviors for childhood cancer survivors as key opportunities for stimulating health behavior adoption in childhood cancer survivors. Incorporating health behavior support and interventions for this population should therefore be a high priority.

Published
2023
Full Text
View/download PDF

24. Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe

Author

Fidler, Miranda M., Reulen, Raoul C., Winter, David L., Allodji, Rodrigue S., Bagnasco, Francesca, Bárdi, Edit, Bautz, Andrea, Bright, Chloe J., Byrne, Julianne, Feijen, Elizabeth A. M., Garwicz, Stanislaw, Grabow, Desiree, Gudmundsdottir, Thorgerdur, Guha, Joyeeta, Haddy, Nadia, Jankovic, Momcilo, Kaatsch, Peter, Kaiser, Melanie, Kuonen, Rahel, Linge, Helena, Maule, Milena, Merletti, Franco, Øfstaas, Hilde, Ronckers, Cecile M., Skinner, Roderick, Teepen, Jop, Terenziani, Monica, Vu-Bezin, Giao, Wesenberg, Finn, Wiebe, Thomas, Jakab, Zsuzsanna, Haupt, Riccardo, Lähteenmäki, Päivi, Zaletel, Lorna Zadravec, Kuehni, Claudia E., Winther, Jeanette F., de Vathaire, Florent, Kremer, Leontien C., Hjorth, Lars, and Hawkins, Michael M.

Published
2018
Full Text
View/download PDF

26. Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer

Author

Zorg en O&O, Cancer, Child Health, MS Radiotherapie, Wang, Yuehan, Ronckers, Cécile M., van Leeuwen, Flora E., Moskowitz, Chaya S., Leisenring, Wendy, Armstrong, Gregory T., de Vathaire, Florent, Hudson, Melissa M., Kuehni, Claudia E., Arnold, Michael A., Demoor-Goldschmidt, Charlotte, Green, Daniel M., Henderson, Tara O., Howell, Rebecca M., Ehrhardt, Matthew J., Neglia, Joseph P., Oeffinger, Kevin C., van der Pal, Helena J.H., Robison, Leslie L., Schaapveld, Michael, Turcotte, Lucie M., Waespe, Nicolas, Kremer, Leontien C.M., Teepen, Jop C., Haddy, Nadia, Diallo, Ibrahima, Baker, K. Scott, de González, Amy Berrington, Conces, Miriam R., Constine, Louis S., Hawkins, Mike, Loonen, Jacqueline J., Louwerens, Marloes, Janssens, Geert O., Mellemkjaer, Lene, Reulen, Raoul, Winther, Jeanette F., Zorg en O&O, Cancer, Child Health, MS Radiotherapie, Wang, Yuehan, Ronckers, Cécile M., van Leeuwen, Flora E., Moskowitz, Chaya S., Leisenring, Wendy, Armstrong, Gregory T., de Vathaire, Florent, Hudson, Melissa M., Kuehni, Claudia E., Arnold, Michael A., Demoor-Goldschmidt, Charlotte, Green, Daniel M., Henderson, Tara O., Howell, Rebecca M., Ehrhardt, Matthew J., Neglia, Joseph P., Oeffinger, Kevin C., van der Pal, Helena J.H., Robison, Leslie L., Schaapveld, Michael, Turcotte, Lucie M., Waespe, Nicolas, Kremer, Leontien C.M., Teepen, Jop C., Haddy, Nadia, Diallo, Ibrahima, Baker, K. Scott, de González, Amy Berrington, Conces, Miriam R., Constine, Louis S., Hawkins, Mike, Loonen, Jacqueline J., Louwerens, Marloes, Janssens, Geert O., Mellemkjaer, Lene, Reulen, Raoul, and Winther, Jeanette F.

Published
2023

28. Person-centred online lifestyle coaching in childhood, adolescent, and young adult cancer survivors: protocol of the multicentre PanCareFollowUp lifestyle intervention feasibility study

Author

Bouwman, Eline, Hermens, Rosella P. M. G., Brown, Morven C., Araújo-Soares, Vera, Blijlevens, Nicole M. A., Kepak, Tomas, Kepakova, Katerina, Kremer, Leontien C. M., van den Oever, Selina R., van der Pal, Helena J. H., Skinner, Roderick, Pluijm, Saskia M. F., Loonen, Jacqueline J., Mulder, Renée L., van Kalsbeek, Rebecca J., Hjorth, Lars, Follin, Cecilia, Eriksson, Lill, Relander, Thomas, Engellau, Jacob, Fjordén, Karin, Bogefors, Karolina, Holmqvist, Anna S., Haupt, Riccardo, Muraca, Monica, Nicolas, Brigitte, Bagnasco, Francesca, Benvenuto, Marina, Aulicino, Anna, Laudisi, Luca, Hrstkova, Hana, Bajciova, Viera, Holikova, Marta, Strublova, Lucie, Uyttebroeck, Anne, Renard, Marleen, Jacobs, Sandra, Segers, Heidi, van Helvoirt, Monique, Winther, Jeanette F., Mader, Luzius, Frederiksen, Line E., Andersen, Elisabeth A. W., Michel, Gisela, Boes, Stefan, Roser, Katharina, Göttgens, Irene, Stollman, Iridi, Penson, Adriaan, Breij, Dionne, Araujo-Soares, Vera, Essiaf, Samira, Blondeel, Anne, Sciberras, William, Korevaar, Joke, Rijken, Mieke, Kienesberger, Anita, den Hartogh, Jaap, Gsell, Hannah, Schneider, Carina, Bardi, Edit, te Dorsthorst, Jeroen, CCA - Cancer Treatment and Quality of Life, Amsterdam Reproduction & Development (AR&D), Paediatric Oncology, and Paediatrics

Subjects
Physical activity, Motivational interviewing, Medicine (miscellaneous), Person-centred care, Feasibility, and young adult cancer survivors, Coaching, Lifestyle, Childhood, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], Diet, Screen-to-screen, All institutes and research themes of the Radboud University Medical Center, adolescent, eHealth, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Childhood, adolescent, and young adult cancer survivors
Abstract

Background Physical inactivity and unhealthy dietary habits are known to be disadvantageous for the development of late adverse effects in survivors of childhood, adolescent, and young adult cancer. To make interventions, aimed at improving lifestyle, fit into the daily life of survivors, interventions should be designed and delivered in a person-centred way with a limited time burden. As part of the European PanCareFollowUp project, an eHealth intervention was developed to support sustainable changes to physical activity levels and/or diet of childhood, adolescent, and young adult cancer survivors. This feasibility study aims to gain insight into the feasibility and potential effect sizes of the PanCareFollowUp lifestyle intervention. Methods The PanCareFollowUp lifestyle intervention consists of person-centred 3–6 screen-to-screen sessions with a certified lifestyle coach. The intervention will be evaluated with a single-arm pre-post feasibility study conducted at two survivorship care clinics in the Netherlands. A total of 60 participants who are (i) diagnosed with cancer Discussion Data of this study will be gathered to assess the feasibility and potential effect sizes. This will allow for further intervention refinement as needed as well as to inform a future large-scale intervention study and a manual for implementation at other centres. Trial registration International Clinical Trial Registry Platform (ICTRP) number: NL8932 (ICTRP Search Portal (who.int)). Registered on September 29, 2020.

Published
2022

29. Risk of subsequent primary lymphoma in a cohort of 69,460 five‐year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study

Author

Dudley, Isabelle M., primary, Sunguc, Ceren, additional, Heymer, Emma J., additional, Winter, David L., additional, Teepen, Jop C., additional, Belle, Fabiën N., additional, Bárdi, Edit, additional, Bagnasco, Francesca, additional, Gudmundsdottir, Thorgerdur, additional, Skinner, Roderick, additional, Michel, Gisela, additional, Byrne, Julianne, additional, Øfstaas, Hilde, additional, Jankovic, Momcilo, additional, Mazić, Maja Česen, additional, Mader, Luzius, additional, Loonen, Jaqueline, additional, Garwicz, Stanislaw, additional, Wiebe, Thomas, additional, Alessi, Daniela, additional, Allodji, Rodrigue S., additional, Haddy, Nadia, additional, Grabow, Desiree, additional, Kaatsch, Peter, additional, Kaiser, Melanie, additional, Maule, Milena M., additional, Jakab, Zsuzsanna, additional, Gunnes, Maria Winther, additional, Terenziani, Monica, additional, Zaletel, Lorna Zadravec, additional, Kuehni, Claudia E., additional, Haupt, Riccardo, additional, de Vathaire, Florent, additional, Kremer, Leontien C., additional, Lähteenmäki, Päivi M., additional, Winther, Jeanette F., additional, Hjorth, Lars, additional, Hawkins, Michael M., additional, and Reulen, Raoul C., additional

Published
2022
Full Text
View/download PDF

30. Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol

Author

van Kalsbeek, Rebecca J, primary, Korevaar, Joke C, additional, Rijken, Mieke, additional, Haupt, Riccardo, additional, Muraca, Monica, additional, Kepák, Tomáš, additional, Kepakova, Katerina, additional, Blondeel, Anne, additional, Boes, Stefan, additional, Frederiksen, Line E, additional, Essiaf, Samira, additional, Winther, Jeanette F, additional, Hermens, Rosella P M G, additional, Kienesberger, Anita, additional, Loonen, Jacqueline J, additional, Michel, Gisela, additional, Mulder, Renée L, additional, O'Brien, Kylie B, additional, van der Pal, Helena J H, additional, Pluijm, Saskia M F, additional, Roser, Katharina, additional, Skinner, Roderick, additional, Renard, Marleen, additional, Uyttebroeck, Anne, additional, Follin, Cecilia, additional, Hjorth, Lars, additional, and Kremer, Leontien C M, additional

Published
2022
Full Text
View/download PDF

31. Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study

Author

Sunguc, Ceren, primary, Hawkins, Michael M., additional, Winter, David L., additional, Dudley, Isabelle M., additional, Heymer, Emma J., additional, Teepen, Jop C., additional, Allodji, Rodrigue S., additional, Belle, Fabiën N., additional, Bagnasco, Francesca, additional, Byrne, Julianne, additional, Bárdi, Edit, additional, Ronckers, Cécile M., additional, Haddy, Nadia, additional, Gudmundsdottir, Thorgerdur, additional, Garwicz, Stanislaw, additional, Jankovic, Momcilo, additional, van der Pal, Helena J. H., additional, Mazić, Maja Česen, additional, Schindera, Christina, additional, Grabow, Desiree, additional, Maule, Milena M., additional, Kaatsch, Peter, additional, Kaiser, Melanie, additional, Fresneau, Brice, additional, Michel, Gisela, additional, Skinner, Roderick, additional, Wiebe, Thomas, additional, Sacerdote, Carlotta, additional, Jakab, Zsuzsanna, additional, Gunnes, Maria Winther, additional, Terenziani, Monica, additional, Winther, Jeanette F., additional, Lähteenmäki, Päivi M., additional, Zaletel, Lorna Zadravec, additional, Kuehni, Claudia E., additional, Kremer, Leontien C., additional, Haupt, Riccardo, additional, de Vathaire, Florent, additional, Hjorth, Lars, additional, and Reulen, Raoul C., additional

Published
2022
Full Text
View/download PDF

34. Cohort profile: life with neurofibromatosis 1 – the Danish NF1 cohort

Author

Doser, Karoline, primary, Hove, Hanne, additional, Østergaard, John R, additional, Bidstrup, Pernille E, additional, Dalton, Susanne O, additional, Handrup, Mette Møller, additional, Ejerskov, Cecilie, additional, Krøyer, Anja, additional, Doherty, Mia Aagaard, additional, Møllegaard Jepsen, Jens Richardt, additional, Mulvihill, John J, additional, Winther, Jeanette F, additional, and Kenborg, Line, additional

Published
2022
Full Text
View/download PDF

37. Perceived barriers and facilitators to health behaviors in European childhood cancer survivors: A qualitative PanCareFollowUp study.

Author

Bouwman, Eline, Pluijm, Saskia M. F., Stollman, Iridi, Araujo‐Soares, Vera, Blijlevens, Nicole M. A., Follin, Cecilia, Winther, Jeanette F., Hjorth, Lars, Kepak, Tomas, Kepakova, Katerina, Kremer, Leontien C. M., Muraca, Monica, van der Pal, Helena J. H., Schneider, Carina, Uyttebroeck, Anne, Vercruysse, Gertrui, Skinner, Rod, Brown, Morven C., Hermens, Rosella P. M. G., and Loonen, Jacqueline J.

Subjects
HEALTH behavior, CHILDHOOD cancer, CANCER survivors, MEDICAL personnel, SOCIAL influence, ALCOHOL drinking
Abstract

Background: Healthy behaviors, that is, engaging in regular physical activities, maintaining a healthy diet, limiting alcohol consumption, and avoiding tobacco and drug use, decrease the risk of developing late adverse health conditions in childhood cancer survivors. However, childhood cancer survivors may experience barriers to adopting and maintaining healthy behaviors. This study aimed to assess these barriers and facilitators to health behavior adoption and maintenance in childhood cancer survivors. Methods: A focus group (n = 12) and semi‐structured telephone interviews (n = 20) were conducted with a selected sample of European and Dutch childhood cancer survivors, respectively. The Theoretical Domains Framework (TDF) was used to inform the topic guide and analysis. Inductive thematic analysis was applied to identify categories relating to barriers and facilitators of health behavior adoption and maintenance, after which they were deductively mapped onto the TDF. Results: Ten TDF domains were identified in the data of which "Knowledge," "Beliefs about consequences," "Environmental context and resources," and "Social influences" were most commonly reported. Childhood cancer survivors expressed a need for knowledge on the importance of healthy behaviors, possibly provided by healthcare professionals. They indicated physical and long‐term benefits of healthy behaviors, available professional support, and a supporting and health‐consciously minded work and social environment to be facilitators. Barriers were mostly related to a lack of available time and an unhealthy environment. Lastly, (social) media was perceived as both a barrier and a facilitator to healthy behaviors. Conclusion: This study has identified education and available professional support in health behaviors and the relevance of healthy behaviors for childhood cancer survivors as key opportunities for stimulating health behavior adoption in childhood cancer survivors. Incorporating health behavior support and interventions for this population should therefore be a high priority. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

39. Pregnancy outcomes in women with neurofibromatosis 1:a Danish population-based cohort study

Author

Kenborg, Line, Boschini, Cristina, Bidstrup, Pernille E., Dalton, Susanne O., Doser, Karoline, Nielsen, Thomas T., Kroyer, Anja, Johansen, Christoffer, Frederiksen, Kirsten, Sorensen, Sven Asger, Hove, Hanne, Ostergaard, John R., Mulvihill, John J., Winther, Jeanette F., Kenborg, Line, Boschini, Cristina, Bidstrup, Pernille E., Dalton, Susanne O., Doser, Karoline, Nielsen, Thomas T., Kroyer, Anja, Johansen, Christoffer, Frederiksen, Kirsten, Sorensen, Sven Asger, Hove, Hanne, Ostergaard, John R., Mulvihill, John J., and Winther, Jeanette F.

Abstract

Background The probability of a pregnancy, live birth, stillbirth and abortion has never been assessed in women with neurofibromatosis 1 (NF1) in a large population-based study. Methods We included 1006 women (15–49 years) registered with NF1 in the Danish National Patient Registry or followed in two national Centers for Rare Diseases and 10 020 women from the Danish population. Information on pregnancy outcomes was ascertained from health registries. Cumulative incidence, mean cumulative count, hazard ratios (HRs) and proportion ratios (PRs) with 95% CIs were calculated. Results The cumulative incidence of a first pregnancy at age 50 years was slightly lower in women with NF1 (74%; 95% CI 70 to 77) than in population comparisons (78%; 95% CI 77 to 79). When all pregnancies were included, two pregnancies were expected per woman at age of 50 years, irrespective of a NF1 diagnosis. The hazard of a pregnancy did not differ between women with NF1 (HR 1.03; 95% CI 0.95 to 1.11) and the comparisons after adjustment for somatic and psychiatric disease. The proportion of pregnancies that resulted in a live birth was 63% (783/1252) among women NF1 and 68% (8432/12 465) among the comparisons, yielding a PR of 0.95 (95% CI 0.90 to 1.00). The proportions of stillbirths (PR 2.83; 95% CI 1.63 to 4.93) and spontaneous abortions (PR 1.40; 95% CI 1.09 to 1.79) were increased in women with NF1. Conclusions A similar hazard for pregnancy was observed for women with NF1 and population comparisons after adjustment for potential medical consequences of NF1. However, women with NF1 experienced more spontaneous abortions and stillbirths., Background The probability of a pregnancy, live birth, stillbirth and abortion has never been assessed in women with neurofibromatosis 1 (NF1) in a large population-based study. Methods We included 1006 women (15-49 years) registered with NF1 in the Danish National Patient Registry or followed in two national Centers for Rare Diseases and 10 020 women from the Danish population. Information on pregnancy outcomes was ascertained from health registries. Cumulative incidence, mean cumulative count, hazard ratios (HRs) and proportion ratios (PRs) with 95% CIs were calculated. Results The cumulative incidence of a first pregnancy at age 50 years was slightly lower in women with NF1 (74%; 95% CI 70 to 77) than in population comparisons (78%; 95% CI 77 to 79). When all pregnancies were included, two pregnancies were expected per woman at age of 50 years, irrespective of a NF1 diagnosis. The hazard of a pregnancy did not differ between women with NF1 (HR 1.03; 95% CI 0.95 to 1.11) and the comparisons after adjustment for somatic and psychiatric disease. The proportion of pregnancies that resulted in a live birth was 63% (783/1252) among women NF1 and 68% (8432/12 465) among the comparisons, yielding a PR of 0.95 (95% CI 0.90 to 1.00). The proportions of stillbirths (PR 2.83; 95% CI 1.63 to 4.93) and spontaneous abortions (PR 1.40; 95% CI 1.09 to 1.79) were increased in women with NF1. Conclusions A similar hazard for pregnancy was observed for women with NF1 and population comparisons after adjustment for potential medical consequences of NF1. However, women with NF1 experienced more spontaneous abortions and stillbirths.

Published
2022

40. Cohort profile:life with neurofibromatosis 1 - the Danish NF1 cohort

Author

Doser, Karoline, Hove, Hanne, Østergaard, John R., Bidstrup, Pernille E., Dalton, Susanne O., Handrup, Mette Møller, Ejerskov, Cecilie, Krøyer, Anja, Doherty, Mia Aagaard, Møllegaard Jepsen, Jens Richardt, Mulvihill, John J., Winther, Jeanette F., Kenborg, Line, Doser, Karoline, Hove, Hanne, Østergaard, John R., Bidstrup, Pernille E., Dalton, Susanne O., Handrup, Mette Møller, Ejerskov, Cecilie, Krøyer, Anja, Doherty, Mia Aagaard, Møllegaard Jepsen, Jens Richardt, Mulvihill, John J., Winther, Jeanette F., and Kenborg, Line

Abstract

Purpose The Danish neurofibromatosis 1 (NF1) cohort was initiated to study health-related, socioeconomic and psychological consequences of living with the monogenetic disorder NF1 using a nationwide and population-based approach. Participants The cohort includes all 2467 individuals in Denmark who were hospitalised with or due to NF1 from 1977 to 2013 or registered in the RAREDIS Database (1995-2013), a national clinical database for rare diseases, or both. A comparison cohort matched to individuals with NF1 on sex and date of birth was identified in the Civil Registration System (n=20 132). Findings to date All cohort members were linked to the unique Danish registries to obtain information on hospital contacts, birth outcomes, education and partnership. A questionnaire was completed by 244 of the 629 adult cohort members with NF1 registered in the RAREDIS Database to evaluate the psychosocial and emotional burden. Further, neuropsychological tests were performed on 103 adult cohort members with NF1 and 38 adult population comparisons. To date, six studies have been published. Individuals with NF1 had an increased risk for (1) hospitalisation for disorders affecting all organ systems of the body throughout all decades of life, (2) psychiatric disorders, (3) attaining a short or medium long education and (4) not forming a life partner. Women with NF1 had an increased risk for spontaneous abortions and stillbirths. Finally, adults with NF1 had an impaired quality of life and a high need for professional support for physical, psychological and work-related problems, which was partly associated with disease severity and visibility. Future plans The cohort will regularly be updated with newly diagnosed patients in the RAREDIS Database as well as with outcome information in the Danish registries. New studies are in progress to assess other medical and socioeconomic dimensions of living with NF1.

Published
2022

41. Association between Maternal Hormonal Contraception Use and Central Nervous System Tumors in Children

Author

Hargreave, Marie, Mørch, Lina S., Winther, Jeanette F., Schmiegelow, Kjeld, Kjaer, Susanne K., Hargreave, Marie, Mørch, Lina S., Winther, Jeanette F., Schmiegelow, Kjeld, and Kjaer, Susanne K.

Abstract

Importance: The incidence of central nervous system (CNS) tumors in children appears to be increasing, yet few risk factors are established. There is limited information regarding whether maternal hormonal contraception use increases this risk. Objective: To examine the association between maternal hormonal contraception use and CNS tumors in children (<20 years). Design, Setting, and Participants: In this nationwide cohort study based on population-based registry data, 1185063 children born in Denmark between January 1, 1996, and December 31, 2014, were followed up for a diagnosis of a CNS tumor (final follow-up on December 31, 2018). Exposures: Maternal hormonal contraception use was analyzed according to any use, regimen (combined/progestin only), and route of administration (oral/nonoral), categorized as recent use (=3 months before start and during pregnancy), previous use (>3 months before start of pregnancy), and no use. For injections, implants, and intrauterine devices that are used for a different time period, the categorization was appropriately altered. Main Outcomes and Measures: Hazard ratio (HR) and incidence rate difference (IRD) of CNS tumors diagnosed at younger than 20 years. Results: After 15335990 person-years of follow-up (mean follow-up, 12.9 years), 725 children were diagnosed with a CNS tumor. The mean age at diagnosis was 7 years, and 342 (47.2%) of the diagnosed children were female. The adjusted incidence rate of CNS tumors per 100000 person-years was 5.0 for children born to mothers with recent hormonal contraception use (n = 136022), 4.5 for children born to mothers with previous use (n = 778843), and 5.3 for children born to mothers with no use (n = 270198). The corresponding HRs were 0.95 ([95% CI, 0.74-1.23]; 84 children with CNS tumors; IRD, -0.3 [95% CI, -1.6 to 1.0]) for recent use and 0.86 ([95% CI, 0.72-1.02]; 421 children with CNS tumors; IRD, -0.8 [95% CI, -1.7 to 0.0]) for previous use, compared with no use. No stati

Published
2022

42. Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol

Author

Von Kalsbeek, Rebecca J., Korevaar, Joke C., Rijken, Mieke, Haupt, Riccardo, Muraca, Monica, Kepák, Tomáš, Kepakova, Katerina, Blondeel, Anne, Boes, Stefan, Frederiksen, Line E, Essiaf, Samira, Winther, Jeanette F, Hermens, Rosella P M G, Kienesberger, Anita, Loonen, Jacqueline J, Michel, Gisela, Mulder, Renée L, O'Brien, Kylie B, van der Pal, Helena J H, Pluijm, Saskia M F, Roser, Katharina, Skinner, Roderick, Renard, Marleen, Uyttebroeck, Anne, Follin, Cecilia, Hjorth, Lars, Kremer, Leontien C M, Von Kalsbeek, Rebecca J., Korevaar, Joke C., Rijken, Mieke, Haupt, Riccardo, Muraca, Monica, Kepák, Tomáš, Kepakova, Katerina, Blondeel, Anne, Boes, Stefan, Frederiksen, Line E, Essiaf, Samira, Winther, Jeanette F, Hermens, Rosella P M G, Kienesberger, Anita, Loonen, Jacqueline J, Michel, Gisela, Mulder, Renée L, O'Brien, Kylie B, van der Pal, Helena J H, Pluijm, Saskia M F, Roser, Katharina, Skinner, Roderick, Renard, Marleen, Uyttebroeck, Anne, Follin, Cecilia, Hjorth, Lars, and Kremer, Leontien C M

Abstract

Introduction: Long-term survival after childhood cancer often comes at the expense of late, adverse health conditions. However, survivorship care is frequently not available for adult survivors in Europe. The PanCareFollowUp Consortium therefore developed the PanCareFollowUp Care Intervention, an innovative person-centred survivorship care model based on experiences in the Netherlands. This paper describes the protocol of the prospective cohort study (Care Study) to evaluate the feasibility and the health economic, clinical and patient-reported outcomes of implementing PanCareFollowUp Care as usual care in four European countries.Methods and analysis In this prospective, longitudinal cohort study with at least 6 months of follow-up, 800 childhood cancer survivors will receive the PanCareFollowUp Care Intervention across four study sites in Belgium, Czech Republic, Italy and Sweden, representing different healthcare systems. The PanCareFollowUp Care Intervention will be evaluated according to the Reach, Effectiveness, Adoption, Implementation and Maintenance framework. Clinical and research data are collected through questionnaires, a clinic visit for multiple medical assessments and a follow-up call. The primary outcome is empowerment, assessed with the Health Education Impact Questionnaire. A central data centre will perform quality checks, data cleaning and data validation, and provide support in data analysis. Multilevel models will be used for repeated outcome measures, with subgroup analysis, for example, by study site, attained age, sex or diagnosis.Ethics and dissemination This study will be conducted in accordance with the guidelines of Good Clinical Practice and the Declaration of Helsinki. The study protocol has been reviewed and approved by all relevant ethics committees. The evidence and insights gained by this study will be summarised in a Replication Manual, also including the tools required to implement the PanCareFollowUp Care Interve, + ID der Publikation: unilu_61784 + Sprache: Englisch + Letzte Aktualisierung: 2022-11-30 17:16:31

Published
2022

43. Late mortality among survivors of childhood acute lymphoblastic leukemia diagnosed during 1971–2008 in Denmark, Finland, and Sweden:A population-based cohort study

Author

Sørensen, Gitte V., Belmonte, Federica, Erdmann, Friederike, Mogensen, Hanna, Albieri, Vanna, Holmqvist, Anna S., Madanat-Harjuoja, Laura, Talbäck, Mats, Heyman, Mats M., Malila, Nea, Feychting, Maria, Schmiegelow, Kjeld, Winther, Jeanette F., Hasle, Henrik, Sørensen, Gitte V., Belmonte, Federica, Erdmann, Friederike, Mogensen, Hanna, Albieri, Vanna, Holmqvist, Anna S., Madanat-Harjuoja, Laura, Talbäck, Mats, Heyman, Mats M., Malila, Nea, Feychting, Maria, Schmiegelow, Kjeld, Winther, Jeanette F., and Hasle, Henrik

Abstract

Objective: Investigate all-cause and cause-specific late mortality after childhood acute lymphoblastic leukemia (ALL) in a population-based Nordic cohort. Methods: From the cancer registries of Denmark, Finland, and Sweden, we identified 3765 five-year survivors of ALL, diagnosed before age 20 during 1971–2008. For each survivor, up to five matched comparison subjects were randomly selected from the general population (n = 18,323). Causes of death were classified as relapse related, health related, and external. Late mortality was evaluated by cumulative incidences of death from 5-year survival date. Mortality hazard ratios (HR) were evaluated with Cox proportional models. Results: Among the survivors, 315 deaths occurred during a median follow-up of 16 years from 5-year survival date (range 0–42). The majority were attributable to relapse (n = 224), followed by second neoplasm (n = 45). Cumulative incidence of all-cause late mortality at 15 years from diagnosis decreased gradually over treatment decades, from 14.4% (95% confidence interval [CI]: 11.6–17.2) for survivors diagnosed during 1971–1981, to 2.5% (95% CI: 1.3–3.7) for those diagnosed during 2002–2008. This was mainly attributable to a reduction in relapse-related deaths decreasing from 13.4% (95% CI: 10.7–16.1) for survivors diagnosed during 1971–1981 to 1.9% (95% CI: 0.9–2.8) for those diagnosed during 2002–2008. Health-related late mortality was low and did not change substantially across treatment decades. Compared to comparison subjects, all-cause mortality HR was 40 (95% CI: 26–61) 5–9 years from diagnosis, and 4.4 (95% CI: 3.4–5.6) ≥10 years from diagnosis. Conclusions: Survivors of ALL have higher late mortality than population comparison subjects. Among the survivors, there was a temporal reduction in risk of death from relapse, without increments in health-related death.

Published
2022

44. Male breast cancer after childhood cancer: Systematic review and analyses in the PanCareSurFup cohort

Author

Wang, Yuehan, primary, Reulen, Raoul C., additional, Kremer, Leontien C.M., additional, de Vathaire, Florent, additional, Haupt, Riccardo, additional, Zadravec Zaletel, Lorna, additional, Bagnasco, Francesca, additional, Demoor-Goldschmidt, Charlotte, additional, van Dorp, Willem J., additional, Haddy, Nadia, additional, Hjorth, Lars, additional, Jakab, Zsuzsanna, additional, Kuehni, Claudia E., additional, Lähteenmäki, Päivi M., additional, van der Pal, Helena J.H., additional, Sacerdote, Carlotta, additional, Skinner, Roderick, additional, Terenziani, Monica, additional, Wesenberg, Finn, additional, Winther, Jeanette F., additional, van Leeuwen, Flora E., additional, Hawkins, Mike M., additional, Teepen, Jop C., additional, van Dalen, Elvira C., additional, and Ronckers, Cécile M., additional

Published
2022
Full Text
View/download PDF

45. Neurocognitive function and health-related quality of life in a nationwide cohort of long-term childhood brain tumor survivors.

Author

Helligsoe, Anne Sophie L, Henriksen, Louise T, Kenborg, Line, Lassen-Ramshad, Yasmin, Wu, Lisa M, Winther, Jeanette F, Hasle, Henrik, and Amidi, Ali

Subjects
BRAIN tumors, QUALITY of life, FATIGUE (Physiology), NEUROPSYCHOLOGICAL tests
Abstract

Background Childhood brain tumor survivors are at high risk of late effects, especially neurocognitive impairment. Limited data are available examining neurocognitive function and associations with quality of life (QoL) in childhood brain tumor survivors. Our aim was to examine neurocognitive function in childhood brain tumor survivors, and associations with QoL and symptom burden. Methods Five–year survivors of brain tumors over the age of 15 were identified in the Danish Childhood Cancer Registry (n = 423). Eligible and consenting participants completed neuropsychological tests and questionnaires assessing QoL, insomnia, fatigue, anxiety, and depression. Survivors treated with radiation (n = 59) were statistically compared with survivors not treated with radiation (n = 102). Results In total, 170 survivors participated (40.2% participation rate). Sixty-six percent of the survivors who completed neurocognitive tests (n = 161) exhibited overall neurocognitive impairment. Survivors treated with radiation, especially whole-brain irradiation, exhibited poorer neurocognitive outcomes than survivors not treated with radiation. Neurocognitive outcomes for survivors treated with surgery were below normative expectations. Furthermore, a number of survivors experienced significant fatigue (40%), anxiety (23%), insomnia (13%), and/or depression (6%). Survivors treated with radiation reported lower quality of life (QoL) and higher symptom burden scores than survivors not treated with radiation; particularly in physical functioning, and social functioning with symptoms of fatigue. Neurocognitive impairment was not associated with QoL or symptom burden. Conclusions In this study, a majority of the childhood brain tumor survivors experienced neurocognitive impairment, reduced QoL, and high symptom burden. Although not associated with each other, it is apparent that childhood brain tumor survivors experience not only neurocognitive dysfunction but may also experience QoL impairments and significant symptom burden. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

47. Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study

Author

Clemens, Eva, Broer, Linda, Langer, Thorsten, Uitterlinden, André G., de Vries, Andrica C. H., van Grotel, Martine, Pluijm, Saskia F. M., Binder, Harald, Byrne, Julianne, Broeder, Eline van Dulmen-den, Crocco, Marco, Kaiser, Melanie, Kenborg, Line, Winther, Jeanette F., Rechnitzer, Catherine, Hasle, Henrik, van der Kooi, Anne-Lotte F., Kremer, Leontien C., van der Pal, Heleen, Parfitt, Ross, Deuster, Dirk, Matulat, Peter, Spix, Claudia, Tillmanns, Amelie, Tissing, Wim J. E., Maier, Lara, am Zehnhoff-Dinnesen, Antoinette, Zolk, Oliver, Kaatsch, P., Grabow, D., Campbell, H., O’Brien, K., Kremer, L.C.M., van Dulmen-den Broeder, E., van den Berg, M.H., van den Heuvel-Eibrink, M.M., Borgmann-Staudt, A., Kuehni, C.E., Haupt, R., Kepak, T., Berger, C., Winther, J.F., Kruseova, J., Calaminus, G., Baust, K., Dirksen, U., Kuehni, Claudia E., van den Heuvel-Eibrink, Marry M., Guided Treatment in Optimal Selected Cancer Patients (GUTS), Pediatric surgery, CCA - Cancer biology and immunology, Amsterdam Reproduction & Development (AR&D), Internal Medicine, Pediatrics, and Obstetrics & Gynecology

Subjects
Oncology, Male, Candidate gene, Internationality, Medizin, CHILDREN, VARIANTS, Neoplasms, TPMT, 610 Medicine & health, Child, SURVIVORS, Cumulative dose, Child, Preschool, Molecular Medicine, Sensorineural hearing loss, Female, 360 Social problems & social services, medicine.drug, medicine.medical_specialty, INDUCED HEARING-LOSS, Side effect, Adolescent, Single-nucleotide polymorphism, Antineoplastic Agents, PLATINUM CHEMOTHERAPY, ACYP2, Young Adult, Ototoxicity, Internal medicine, Genetics, medicine, Humans, Hearing Loss, Genetic Association Studies, Retrospective Studies, Pharmacology, Cisplatin, CHILDHOOD-CANCER, business.industry, Infant, Newborn, Genetic Variation, Infant, medicine.disease, COMT, REPLICATION, business
Abstract

Ototoxicity is a common side effect of platinum treatment and manifests as irreversible, high-frequency sensorineural hearing loss. Genetic association studies have suggested a role for SNPs in genes related to the disposition of cisplatin or deafness. In this study, 429 pediatric patients that were treated with cisplatin were genotyped for 10 candidate SNPs. Logistic regression analyses revealed that younger age at treatment (≤5 years vs >15 years: OR: 9.1; 95% CI: 3.8–21.5; P = 5.6 × 10−7) and higher cumulative dose of cisplatin (>450 vs ≤300 mg/m2: OR: 2.4; 95% CI: 1.3–4.6; P = 0.007) confer a significant risk of ototoxicity. Of the SNPs investigated, none of them were significantly associated with an increase of ototoxicity. In the meta-analysis, ACYP2 rs1872328 (OR: 3.94; 95% CI: 1.04–14.03; P = 0.04) and SLC22A2 rs316019 (OR: 1.46; 95% CI: 1.07–2.00; P = 0.02) were associated with ototoxicity. In order to increase the understanding of the association between SNPs and ototoxicity, we propose a polygenic model, which takes into account multiple interacting genes of the cisplatin pathway that together confer an increased risk of ototoxicity.

Published
2020
Full Text
View/download PDF

50. International variation in childhood cancer mortality rates from 2001 to 2015: Comparison of trends in the International Cancer Benchmarking Partnership countries

Author

Smith, Lesley, primary, Stiller, Charles A., additional, Aitken, Joanne F., additional, Hjalgrim, Lisa L., additional, Johannesen, Tom, additional, Lahteenmaki, Paivi, additional, McCabe, Martin G., additional, Phillips, Robert, additional, Pritchard‐Jones, Kathy, additional, Steliarova‐Foucher, Eva, additional, Winther, Jeanette F., additional, Woods, Ryan R., additional, Glaser, Adam W., additional, and Feltbower, Richard G., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results